Psychiatric medication includes all drugs which can be prescribed to treat different types of mental health problem, reduce the symptoms of mental health problems, prevent the return of mental health problems and their symptoms (also known as relapse), etc.

The global Psychiatric Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Psychiatric Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychiatric Medications.

Report Scope

The Psychiatric Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psychiatric Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Psychiatric Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Psychiatric Medications Market Report

Report Metric	Details
Report Name	Psychiatric Medications Market
CAGR	5%
Segment by Type	Antidepressants Anti-anxiety Medications Mood-stabilizing Medications Antipsychotic Medications
Segment by Application	Hospital Use Clinic Use Household
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Novartis, H. Lundbeck, Abbott Laboratories, Otsuka Pharmaceutical, Gedeon Richter, Lupin Pharmaceuticals, Luye Pharma, SK Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psychiatric Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psychiatric Medications Market report?

Ans: The main players in the Psychiatric Medications Market are Pfizer, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Novartis, H. Lundbeck, Abbott Laboratories, Otsuka Pharmaceutical, Gedeon Richter, Lupin Pharmaceuticals, Luye Pharma, SK Biopharmaceuticals

What are the Application segmentation covered in the Psychiatric Medications Market report?

Ans: The Applications covered in the Psychiatric Medications Market report are Hospital Use, Clinic Use, Household

What are the Type segmentation covered in the Psychiatric Medications Market report?

Ans: The Types covered in the Psychiatric Medications Market report are Antidepressants, Anti-anxiety Medications, Mood-stabilizing Medications, Antipsychotic Medications

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Psychiatric Medications Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antidepressants

1.2.3 Anti-anxiety Medications

1.2.4 Mood-stabilizing Medications

1.2.5 Antipsychotic Medications

1.3 Market by Application

1.3.1 Global Psychiatric Medications Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Use

1.3.3 Clinic Use

1.3.4 Household

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Psychiatric Medications Market Perspective (2019-2030)

2.2 Psychiatric Medications Growth Trends by Region

2.2.1 Global Psychiatric Medications Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Psychiatric Medications Historic Market Size by Region (2019-2024)

2.2.3 Psychiatric Medications Forecasted Market Size by Region (2025-2030)

2.3 Psychiatric Medications Market Dynamics

2.3.1 Psychiatric Medications Industry Trends

2.3.2 Psychiatric Medications Market Drivers

2.3.3 Psychiatric Medications Market Challenges

2.3.4 Psychiatric Medications Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Psychiatric Medications Players by Revenue

3.1.1 Global Top Psychiatric Medications Players by Revenue (2019-2024)

3.1.2 Global Psychiatric Medications Revenue Market Share by Players (2019-2024)

3.2 Global Psychiatric Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Psychiatric Medications Revenue

3.4 Global Psychiatric Medications Market Concentration Ratio

3.4.1 Global Psychiatric Medications Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Psychiatric Medications Revenue in 2023

3.5 Psychiatric Medications Key Players Head office and Area Served

3.6 Key Players Psychiatric Medications Product Solution and Service

3.7 Date of Enter into Psychiatric Medications Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Psychiatric Medications Breakdown Data by Type

4.1 Global Psychiatric Medications Historic Market Size by Type (2019-2024)

4.2 Global Psychiatric Medications Forecasted Market Size by Type (2025-2030)

5 Psychiatric Medications Breakdown Data by Application

5.1 Global Psychiatric Medications Historic Market Size by Application (2019-2024)

5.2 Global Psychiatric Medications Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Psychiatric Medications Market Size (2019-2030)

6.2 North America Psychiatric Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Psychiatric Medications Market Size by Country (2019-2024)

6.4 North America Psychiatric Medications Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Psychiatric Medications Market Size (2019-2030)

7.2 Europe Psychiatric Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Psychiatric Medications Market Size by Country (2019-2024)

7.4 Europe Psychiatric Medications Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Psychiatric Medications Market Size (2019-2030)

8.2 Asia-Pacific Psychiatric Medications Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Psychiatric Medications Market Size by Region (2019-2024)

8.4 Asia-Pacific Psychiatric Medications Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Psychiatric Medications Market Size (2019-2030)

9.2 Latin America Psychiatric Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Psychiatric Medications Market Size by Country (2019-2024)

9.4 Latin America Psychiatric Medications Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Psychiatric Medications Market Size (2019-2030)

10.2 Middle East & Africa Psychiatric Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Psychiatric Medications Market Size by Country (2019-2024)

10.4 Middle East & Africa Psychiatric Medications Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Psychiatric Medications Introduction

11.1.4 Pfizer Revenue in Psychiatric Medications Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Detail

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Psychiatric Medications Introduction

11.2.4 AstraZeneca Revenue in Psychiatric Medications Business (2019-2024)

11.2.5 AstraZeneca Recent Development

11.3 Eli Lilly and Company

11.3.1 Eli Lilly and Company Company Detail

11.3.2 Eli Lilly and Company Business Overview

11.3.3 Eli Lilly and Company Psychiatric Medications Introduction

11.3.4 Eli Lilly and Company Revenue in Psychiatric Medications Business (2019-2024)

11.3.5 Eli Lilly and Company Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Detail

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Psychiatric Medications Introduction

11.4.4 GlaxoSmithKline Revenue in Psychiatric Medications Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Detail

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Psychiatric Medications Introduction

11.5.4 Johnson & Johnson Revenue in Psychiatric Medications Business (2019-2024)

11.5.5 Johnson & Johnson Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Psychiatric Medications Introduction

11.6.4 Novartis Revenue in Psychiatric Medications Business (2019-2024)

11.6.5 Novartis Recent Development

11.7 H. Lundbeck

11.7.1 H. Lundbeck Company Detail

11.7.2 H. Lundbeck Business Overview

11.7.3 H. Lundbeck Psychiatric Medications Introduction

11.7.4 H. Lundbeck Revenue in Psychiatric Medications Business (2019-2024)

11.7.5 H. Lundbeck Recent Development

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Detail

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories Psychiatric Medications Introduction

11.8.4 Abbott Laboratories Revenue in Psychiatric Medications Business (2019-2024)

11.8.5 Abbott Laboratories Recent Development

11.9 Otsuka Pharmaceutical

11.9.1 Otsuka Pharmaceutical Company Detail

11.9.2 Otsuka Pharmaceutical Business Overview

11.9.3 Otsuka Pharmaceutical Psychiatric Medications Introduction

11.9.4 Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2019-2024)

11.9.5 Otsuka Pharmaceutical Recent Development

11.10 Gedeon Richter

11.10.1 Gedeon Richter Company Detail

11.10.2 Gedeon Richter Business Overview

11.10.3 Gedeon Richter Psychiatric Medications Introduction

11.10.4 Gedeon Richter Revenue in Psychiatric Medications Business (2019-2024)

11.10.5 Gedeon Richter Recent Development

11.11 Lupin Pharmaceuticals

11.11.1 Lupin Pharmaceuticals Company Detail

11.11.2 Lupin Pharmaceuticals Business Overview

11.11.3 Lupin Pharmaceuticals Psychiatric Medications Introduction

11.11.4 Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2019-2024)

11.11.5 Lupin Pharmaceuticals Recent Development

11.12 Luye Pharma

11.12.1 Luye Pharma Company Detail

11.12.2 Luye Pharma Business Overview

11.12.3 Luye Pharma Psychiatric Medications Introduction

11.12.4 Luye Pharma Revenue in Psychiatric Medications Business (2019-2024)

11.12.5 Luye Pharma Recent Development

11.13 SK Biopharmaceuticals

11.13.1 SK Biopharmaceuticals Company Detail

11.13.2 SK Biopharmaceuticals Business Overview

11.13.3 SK Biopharmaceuticals Psychiatric Medications Introduction

11.13.4 SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2019-2024)

11.13.5 SK Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Astrazeneca plc

Eli Lilly and Company

Otsuka Pharmaceutical

Gedeon Richter

Lupin Pharmaceuticals

Luye Pharma

SK Biopharmaceuticals

List of Tables

Table 1. Global Psychiatric Medications Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antidepressants

Table 3. Key Players of Anti-anxiety Medications

Table 4. Key Players of Mood-stabilizing Medications

Table 5. Key Players of Antipsychotic Medications

Table 6. Global Psychiatric Medications Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Psychiatric Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Psychiatric Medications Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Psychiatric Medications Market Share by Region (2019-2024)

Table 10. Global Psychiatric Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Psychiatric Medications Market Share by Region (2025-2030)

Table 12. Psychiatric Medications Market Trends

Table 13. Psychiatric Medications Market Drivers

Table 14. Psychiatric Medications Market Challenges

Table 15. Psychiatric Medications Market Restraints

Table 16. Global Psychiatric Medications Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Psychiatric Medications Market Share by Players (2019-2024)

Table 18. Global Top Psychiatric Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychiatric Medications as of 2023)

Table 19. Ranking of Global Top Psychiatric Medications Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Psychiatric Medications Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Psychiatric Medications Product Solution and Service

Table 23. Date of Enter into Psychiatric Medications Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Psychiatric Medications Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Psychiatric Medications Revenue Market Share by Type (2019-2024)

Table 27. Global Psychiatric Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Psychiatric Medications Revenue Market Share by Type (2025-2030)

Table 29. Global Psychiatric Medications Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Psychiatric Medications Revenue Market Share by Application (2019-2024)

Table 31. Global Psychiatric Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Psychiatric Medications Revenue Market Share by Application (2025-2030)

Table 33. North America Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Psychiatric Medications Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Psychiatric Medications Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Psychiatric Medications Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Psychiatric Medications Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Psychiatric Medications Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Psychiatric Medications Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Psychiatric Medications Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Psychiatric Medications Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Psychiatric Medications Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Psychiatric Medications Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Psychiatric Medications Market Size by Country (2025-2030) & (US$ Million)

Table 48. Pfizer Company Detail

Table 49. Pfizer Business Overview

Table 50. Pfizer Psychiatric Medications Product

Table 51. Pfizer Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. AstraZeneca Company Detail

Table 54. AstraZeneca Business Overview

Table 55. AstraZeneca Psychiatric Medications Product

Table 56. AstraZeneca Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 57. AstraZeneca Recent Development

Table 58. Eli Lilly and Company Company Detail

Table 59. Eli Lilly and Company Business Overview

Table 60. Eli Lilly and Company Psychiatric Medications Product

Table 61. Eli Lilly and Company Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 62. Eli Lilly and Company Recent Development

Table 63. GlaxoSmithKline Company Detail

Table 64. GlaxoSmithKline Business Overview

Table 65. GlaxoSmithKline Psychiatric Medications Product

Table 66. GlaxoSmithKline Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 67. GlaxoSmithKline Recent Development

Table 68. Johnson & Johnson Company Detail

Table 69. Johnson & Johnson Business Overview

Table 70. Johnson & Johnson Psychiatric Medications Product

Table 71. Johnson & Johnson Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 72. Johnson & Johnson Recent Development

Table 73. Novartis Company Detail

Table 74. Novartis Business Overview

Table 75. Novartis Psychiatric Medications Product

Table 76. Novartis Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 77. Novartis Recent Development

Table 78. H. Lundbeck Company Detail

Table 79. H. Lundbeck Business Overview

Table 80. H. Lundbeck Psychiatric Medications Product

Table 81. H. Lundbeck Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 82. H. Lundbeck Recent Development

Table 83. Abbott Laboratories Company Detail

Table 84. Abbott Laboratories Business Overview

Table 85. Abbott Laboratories Psychiatric Medications Product

Table 86. Abbott Laboratories Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 87. Abbott Laboratories Recent Development

Table 88. Otsuka Pharmaceutical Company Detail

Table 89. Otsuka Pharmaceutical Business Overview

Table 90. Otsuka Pharmaceutical Psychiatric Medications Product

Table 91. Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 92. Otsuka Pharmaceutical Recent Development

Table 93. Gedeon Richter Company Detail

Table 94. Gedeon Richter Business Overview

Table 95. Gedeon Richter Psychiatric Medications Product

Table 96. Gedeon Richter Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 97. Gedeon Richter Recent Development

Table 98. Lupin Pharmaceuticals Company Detail

Table 99. Lupin Pharmaceuticals Business Overview

Table 100. Lupin Pharmaceuticals Psychiatric Medications Product

Table 101. Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 102. Lupin Pharmaceuticals Recent Development

Table 103. Luye Pharma Company Detail

Table 104. Luye Pharma Business Overview

Table 105. Luye Pharma Psychiatric Medications Product

Table 106. Luye Pharma Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 107. Luye Pharma Recent Development

Table 108. SK Biopharmaceuticals Company Detail

Table 109. SK Biopharmaceuticals Business Overview

Table 110. SK Biopharmaceuticals Psychiatric Medications Product

Table 111. SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2019-2024) & (US$ Million)

Table 112. SK Biopharmaceuticals Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Psychiatric Medications Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Psychiatric Medications Market Share by Type: 2023 VS 2030

Figure 3. Antidepressants Features

Figure 4. Anti-anxiety Medications Features

Figure 5. Mood-stabilizing Medications Features

Figure 6. Antipsychotic Medications Features

Figure 7. Global Psychiatric Medications Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Psychiatric Medications Market Share by Application: 2023 VS 2030

Figure 9. Hospital Use Case Studies

Figure 10. Clinic Use Case Studies

Figure 11. Household Case Studies

Figure 12. Psychiatric Medications Report Years Considered

Figure 13. Global Psychiatric Medications Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Psychiatric Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Psychiatric Medications Market Share by Region: 2023 VS 2030

Figure 16. Global Psychiatric Medications Market Share by Players in 2023

Figure 17. Global Top Psychiatric Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychiatric Medications as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Psychiatric Medications Revenue in 2023

Figure 19. North America Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Psychiatric Medications Market Share by Country (2019-2030)

Figure 21. United States Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Psychiatric Medications Market Share by Country (2019-2030)

Figure 25. Germany Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Psychiatric Medications Market Share by Region (2019-2030)

Figure 33. China Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Psychiatric Medications Market Share by Country (2019-2030)

Figure 41. Mexico Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Psychiatric Medications Market Share by Country (2019-2030)

Figure 45. Turkey Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Psychiatric Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 48. AstraZeneca Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 49. Eli Lilly and Company Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 50. GlaxoSmithKline Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 51. Johnson & Johnson Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 52. Novartis Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 53. H. Lundbeck Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 54. Abbott Laboratories Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 55. Otsuka Pharmaceutical Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 56. Gedeon Richter Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 57. Lupin Pharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 58. Luye Pharma Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 59. SK Biopharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions